621P Phase II trial of encorafenib and binimetinib (E+B) in patients (pts) with BRAF-altered advanced solid tumors: Results of E+B cohort in the BELIEVE trial (NCCH1901)
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.08.688